学士，复旦大学

硕士，香港科技大学

博士，加拿大卡尔加里大学

博士后，美国哈佛大学医学院

美国肿瘤研究学会(AACR)高级会员 加拿大分子生物科学学会(CSMB)会员 Journal of Cellular and Molecular Medicine 评委 Biochemistry and Cell Biology 评委 Molecular BioSystems 评委 Journal of Tumor 编辑 国家自然科学基金评审专家

1. S Zhu, JD Bjorge, DJ Fujita. (2007). PTP1B Contributes to the Oncogenic Properties of Colon Cancer Cells through Src Activation. Cancer Research, 67(21): 10129-10137.

2. S Zhu, JD Bjorge, H-C Cheng, DJ Fujita. (2008). Decreased CHK protein levels are associated with Src activation in colon cancer cells. Oncogene, 27(14): 2027-2034.

3. A Singh, M Ye, O Bucur, S Zhu, M Tanya Santos, I Rabinovitz, W Wei, D Gao, WC Hahn, R Khosravi-Far. (2010) Protein Phosphatase 2A Reactivates FOXO3a Through A Dynamic Interplay with 14-3-3 and AKT. Mol. Biol. Cell, 21(6): 1140-1152.

4. S Zhu*, MB Cohen, JD Bjorge, JW Mier, DC Cho*. (2013) PI3K inhibition potentiates Bcl-2 dependent apoptosis in renal carcinoma cells. Journal of Cellular and Molecular Medicine. 17(3): 377-385. (*corresponding author).

5. Chen F, Liu X, Cheng Q, Zhu S*, Bai J*, Zheng J*. RUNX3 regulates renal cell carcinoma metastasis via targeting miR-6780a-5p/E-cadherin/EMT signaling axis. Oncotarget. 2017 Nov 8;8(60):101042-101056. (*corresponding author).